Shepherd Kaplan Krochuk’s iShares Biotechnology ETF IBB Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,856	Closed	-$281K	–	191
2020 Q4	$281K	Hold	1,856	–	–	0.1%	145
2020 Q3	$251K	Hold	1,856	–	–	0.1%	138
2020 Q2	$254K	Buy	+1,856	New	+$237K	0.11%	136
2020 Q1	–	Sell	-1,856	Closed	-$224K	–	152
2019 Q4	$224K	Buy	+1,856	New	+$207K	0.17%	136
2019 Q3	–	Sell	-1,856	Closed	-$202K	–	168
2019 Q2	$202K	Sell	1,856 -6,697	-78%	-$712K	0.14%	143
2019 Q1	$956K	Buy	8,553 +1,629	+24%	+$179K	0.6%	44
2018 Q4	$668K	Sell	6,924 -10,932	-61%	-$1.16M	0.46%	60
2018 Q3	$2.18M	Buy	17,856 +1,751	+11%	+$206K	1.12%	17
2018 Q2	$1.77M	Sell	16,105 -37	-0.2%	-$3.96K	1.08%	17
2018 Q1	$1.72M	Buy	16,142 +56	+0.3%	+$6.21K	1.05%	18
2017 Q4	$1.72M	Buy	+16,086	New	+$1.72M	1.07%	20
2014 Q1	–	Sell	-4,500	Closed	-$375K	–	613
2013 Q4	$341K	Buy	+4,500	New	+$319K	0.04%	275

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Shepherd Kaplan Krochuk's IBB Position: Q1 2021 in Review

Shepherd Kaplan Krochuk sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 1,856 shares — an estimated $281K sold.

Shepherd Kaplan Krochuk first reported a position in IBB in Q4 2013 and held it in 12 quarters. The position peaked at $2.18M in Q3 2018. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Shepherd Kaplan Krochuk reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 1,856 iShares Biotechnology ETF shares in Q1 2021, an estimated $281K.
Shepherd Kaplan Krochuk first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 12 quarters.
Shepherd Kaplan Krochuk's iShares Biotechnology ETF position peaked at $2.18M in Q3 2018.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2021, filed 17 May 2021.